Literature DB >> 2173795

Production of human papillomavirus type 16 virions in a keratinocyte cell line.

J Sterling1, M Stanley, G Gatward, T Minson.   

Abstract

Human papillomavirus type 16 (HPV-16) is strongly associated with carcinoma of the cervix, but the complete life cycle of the virus cannot be studied because no experimental system is available in which HPV-16 progeny are produced, and there is currently no source of HPV-16 virus particles. Most cell lines that harbor HPV-16 DNA contain the viral genome as integrated or concatenated DNA in which open reading frames are disrupted or deleted, but a human cervical keratinocyte cell line has been described which maintains HPV-16 DNA in monomeric episomal form (M.A. Stanley, H.M. Brown, M.W. Appleby, and A.C. Minson, Int. J. Cancer 43:672-676, 1989). This cell line was induced to form a stratified differentiating epithelium by grafting onto nude mice. Long-term grafts displayed the histological features of a low-grade cervical dysplasia, and terminally differentiated cells contained amplified levels of HPV-16 DNA, virus capsid antigen, and virus particles. This experimental system appears to permit the completion of the HPV-16 life cycle in virus-containing keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173795      PMCID: PMC248810          DOI: 10.1128/JVI.64.12.6305-6307.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  15 in total

1.  Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri.

Authors:  P G Fuchs; F Girardi; H Pfister
Journal:  Int J Cancer       Date:  1988-01-15       Impact factor: 7.396

2.  Distribution pattern of human papilloma virus 16 genome in cervical neoplasia by molecular in situ hybridization of tissue sections.

Authors:  A Schneider; T Oltersdorf; V Schneider; L Gissmann
Journal:  Int J Cancer       Date:  1987-06-15       Impact factor: 7.396

3.  Laboratory production in vivo of infectious human papillomavirus type 11.

Authors:  J W Kreider; M K Howett; A E Leure-Dupree; R J Zaino; J A Weber
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

4.  Association of human papillomavirus types 16 and 18 E6 proteins with p53.

Authors:  B A Werness; A J Levine; P M Howley
Journal:  Science       Date:  1990-04-06       Impact factor: 47.728

5.  Experimental infection with human papillomavirus type 1 of human hand and foot skin.

Authors:  J W Kreider; S D Patrick; N M Cladel; P A Welsh
Journal:  Virology       Date:  1990-07       Impact factor: 3.616

6.  Growth requirements of human cervical epithelial cells in culture.

Authors:  M A Stanley; E K Parkinson
Journal:  Int J Cancer       Date:  1979-10-15       Impact factor: 7.396

7.  Growth and differentiation characteristics of transformed keratinocytes from mouse and human skin in vitro and in vivo.

Authors:  N E Fusenig; D Breitkreutz; R T Dzarlieva; P Boukamp; A Bohnert; W Tilgen
Journal:  J Invest Dermatol       Date:  1983-07       Impact factor: 8.551

8.  Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA.

Authors:  L Pirisi; S Yasumoto; M Feller; J Doniger; J A DiPaolo
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

9.  Human papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells.

Authors:  G Matlashewski; J Schneider; L Banks; N Jones; A Murray; L Crawford
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

10.  Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

Authors:  K Münger; B A Werness; N Dyson; W C Phelps; E Harlow; P M Howley
Journal:  EMBO J       Date:  1989-12-20       Impact factor: 11.598

View more
  23 in total

Review 1.  Papillomavirus DNA replication.

Authors:  P F Lambert
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle.

Authors:  E R Flores; P F Lambert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Coinfection of human foreskin fragments with multiple human papillomavirus types (HPV-11, -40, and -LVX82/MM7) produces regionally separate HPV infections within the same athymic mouse xenograft.

Authors:  N D Christensen; W A Koltun; N M Cladel; L R Budgeon; C A Reed; J W Kreider; P A Welsh; S D Patrick; H Yang
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

4.  Saccharomyces cerevisiae is permissive for replication of bovine papillomavirus type 1.

Authors:  Kong-Nan Zhao; Ian H Frazer
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

5.  Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined immunodeficiency mouse.

Authors:  W Bonnez; C DaRin; C Borkhuis; K de Mesy Jensen; R C Reichman; R C Rose
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

6.  Human papillomaviruses: a growing field.

Authors:  Denise A Galloway
Journal:  Genes Dev       Date:  2009-01-15       Impact factor: 11.361

7.  Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells.

Authors:  S Jeon; B L Allen-Hoffmann; P F Lambert
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

8.  Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles.

Authors:  R Kirnbauer; J Taub; H Greenstone; R Roden; M Dürst; L Gissmann; D R Lowy; J T Schiller
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

9.  Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism.

Authors:  John H Lee; Su Min P Yi; Mary E Anderson; Kristi L Berger; Michael J Welsh; Aloysius J Klingelhutz; Michelle A Ozbun
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

10.  Transient replication of human papillomavirus DNAs.

Authors:  A M Del Vecchio; H Romanczuk; P M Howley; C C Baker
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.